Adagio Medical Holdings, Inc.
ADGM
NASDAQ·Healthcare·Medical - Devices·Mkt cap $12.5M
$0.56
▲ +4.31%
P/E
—
Mkt Cap
$12.5M
52-Wk Range
$0.36–$2.58
52-Week Range
$0.36 - $2.58
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 59.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary ultra-low temperature cryoablation technology
- Innovative pulsed-field ablation approach
- Focused expertise in cardiac arrhythmia treatment
- Comprehensive product portfolio addressing multiple arrhythmia types
Bear Case
1 risk
- Low volatility (beta -0.2).
Growth
Stable outlook
Rising prevalence of atrial fibrillation globally
Value
Valuation data unavailable
Momentum
Falling
-24.1% over 3m
Quality
Loss-making
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying ADGM right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 11, 2026
AUG 11, 2026
Reported EPS of -$0.30 vs -$0.27 consensus (-11.1% surprise).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-11.1%
Revenue trend · last 8Q
—
—
-100%
-100%
-100%
—
—
—
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$185.0K
-$143.0K
$0
$0
$0
$0
$0
$0
Margins · last 8Q
Profit
—
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How ADGM stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related